✦ LIBER ✦

Targeting epigenetic abnormalities with histone deacetylase inhibitors

✍ Scribed by Barbara A. Conley; John J. Wright; Shivaani Kummar

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 136 KB
Volume: 107
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.22064

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[Methods and Principles in Medicinal Che

[Methods and Principles in Medicinal Chemistry] Epigenetic Targets in Drug Discovery Volume 42 || Histone Deacetylase Inhibitors

✍ Sippl, Wolfgang; Jung, Manfred 📂 Article 📅 2009 🏛 Wiley ⚖ 425 KB 👁 2 views

Novel Histone Deacetylase Inhibitors: Cy

Novel Histone Deacetylase Inhibitors: Cyclic Tetrapeptide with Trifluoromethyl and Pentafluoroethyl Ketones.

✍ Binoy Jose; Yusuke Oniki; Tamaki Kato; Norikazu Nishino; Yuko Sumida; Minoru Yos 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 13 KB 👁 1 views

Molecularly Targeted Approach to Cancer

Molecularly Targeted Approach to Cancer Therapy: Design, Synthesis and Biological Activity of Non-Hydroxamate Histone Deacetylase Inhibitors

✍ Takayoshi Suzuki; Hidehiko Nakagawa; Naoki Miyata 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 8 KB 👁 2 views

Inhibitors of Human Histone Deacetylase:

Inhibitors of Human Histone Deacetylase: Synthesis and Enzyme Assay of Hydroxamates with Piperazine Linker

✍ Shubhashis Chakrabarty; Jasmine; Chetan Bhadaliya; Barij Nayan Sinha; Aruna Mahe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB 👁 1 views

Proteomic profiling of human colon cance

Proteomic profiling of human colon cancer cells treated with the histone deacetylase inhibitor belinostat

✍ Hans Christian Beck; Jørgen Petersen; Søren Jensby Nielsen; Christian Morszeck; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

Chemoprevention of rat hepatocarcinogene

Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: Efficacy of tributyrin, a butyric acid prodrug

✍ Joice Kuroiwa-Trzmielina; Aline de Conti; Clarissa Scolastici; Douglas Pereira; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 272 KB

## Abstract Hepatocellular carcinoma (HCC) ranks in prevalence and mortality among top 10 cancers worldwide. Butyric acid (BA), a member of histone deacetylase inhibitors (HDACi) has been proposed as an anticarcinogenic agent. However, its short half‐life is a therapeutical limitation. This problem